Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
IntestiNorm
- Development stage
- Unknown
- Lead developer
- Laboratoires Ortis
- Modality
- Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Small Molecules, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
IntestiNorm is a 100% natural phytotherapeutic dietary supplement developed by Laboratoires Ortis to manage rapid intestinal transit and associated digestive discomforts such as diarrhea, bloating, and flatulence. The formulation combines plant extracts—bilberry (Vaccinium myrtillus), loosestrife (Lythrum salicaria), and chamomile (Matricaria chamomilla)—with three strains of lactic ferments (Lactobacilli and Bifidobacteria). Bilberry and loosestrife are included to help maintain normal bowel movement frequency and microbiota balance, while chamomile targets flatulence. It is administered orally as a dual-tablet regimen (herbal and probiotic tablets) and is suitable for adults and children over six years of age.
- Brand names
- IntestiNorm
Beyond the preview
Go deeper on IntestiNorm.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on IntestiNorm.